-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Johnson & Johnson, Lowers Price Target to $165

Benzinga·04/17/2025 15:10:16
Listen to the news
Barclays analyst Matt Miksic maintains Johnson & Johnson (NYSE:JNJ) with a Equal-Weight and lowers the price target from $166 to $165.